Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
Antibacterial toxin colicin N and phage protein G3p compete with TolB for a binding site on TolA
Helen Ridley1, Jeremy H Lakey2
1Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Abstract:
Most colicins kill Escherichia coli cells by membrane pore formation or nuclease activity and, superficially, the mechanisms are similar: receptor binding, translocon recruitment, periplasmic receptor binding and membrane insertion. However, in detail, they employ a wide variety of molecular interactions that reveal a high degree of evolutionary diversification. Group A colicins bind to members of the TolQRAB complex in the periplasm and heterotrimeric complexes of colicin-TolA-TolB have been observed for both ColA and ColE9. ColN, the smallest and simplest pore-forming colicin, binds only to TolA and we show here that it uses the binding site normally used by TolB, effectively preventing formation of the larger complex used by other colicins. ColN binding to TolA was by β-strand addition with a KD of 1 µM compared with 40 µM for the TolA-TolB interaction. The β-strand addition and ColN activity could be abolished by single proline point mutations in TolA, which each removed one backbone hydrogen bond. By also blocking TolA-TolB binding these point mutations conferred a complete tol phenotype which destabilized the outer membrane, prevented both ColA and ColE9 activity, and abolished phage protein binding to TolA. These are the only point mutations known to have such pleiotropic effects and showed that the TolA-TolB β-strand addition is essential for Tol function. The formation of this simple binary ColN-TolA complex provided yet more evidence of a distinct translocation route for ColN and may help to explain the unique toxicity of its N-terminal domain.
Insights
Colicin N (ColN) uses a unique binding site on TolA, distinct from other colicins, revealing evolutionary diversification in bacterial toxin mechanisms. This interaction is crucial for outer membrane stability and colicin activity.
Area of Science:
- Microbiology
- Molecular Biology
- Structural Biology
Background:
- Colicins are bacteriocins produced by Escherichia coli that kill related strains.
- Most colicins utilize pore formation or nuclease activity, involving complex interactions with the bacterial cell envelope.
- Group A colicins typically engage the TolQRAB complex for translocation into the cell.
Purpose of the Study:
- To investigate the detailed molecular interactions of Colicin N (ColN) with the TolA protein.
- To elucidate the unique translocation pathway of ColN compared to other colicins.
- To understand the role of the TolA-TolB interaction in outer membrane stability and colicin activity.
Main Methods:
- Biochemical assays to determine binding affinities (KD) between ColN, TolA, and TolB.
- Site-directed mutagenesis of TolA to introduce proline point mutations.
- Phenotypic analysis of mutant strains to assess outer membrane stability, colicin activity, and phage protein binding.
Main Results:
- ColN binds TolA with high affinity (1 µM) via β-strand addition, utilizing the TolB binding site.
- Single proline mutations in TolA abolish both ColN-TolA and TolA-TolB binding, conferring a complete tol phenotype.
- The identified TolA mutations destabilize the outer membrane, inhibit ColA and ColE9 activity, and block phage protein binding.
Conclusions:
- The TolA-TolB β-strand addition is essential for Tol pathway function and outer membrane integrity.
- ColN employs a distinct translocation route, forming a binary complex with TolA, which may explain its unique toxicity.
- Evolutionary diversification in colicin mechanisms is evident in their distinct molecular interactions and translocation strategies.
Related Concept Videos
Bacterial Toxins
Bacterial Gastroenteritis
Regulation of Bacterial Virulence
Inhibitors of Bacterial DNA Synthesis
Viral Replication: Lytic Cycle
Stringent Response in E. coli

